Skip to content
Disclosery

MARSHALL WACE, LLP: SYRE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on SYRE, newest first. How the timeline and the estimate are built.

MARSHALL WACE, LLP held 991,693 SYRE shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 991,693 shares
    Change vs previous 13F +852,434 shares

    0.07% of the 13F portfolio, value $88,042,506.

    13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 139,259 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $7,024,224.

    13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).